Skip to main content
Journals

The Association Between Repeated Lip Augmentation With Hyaluronic Acid Filler and Recurrence of Herpes Labialis: A Longitudinal Self-controlled Study

Aesthetic Surgery Journal Open Forum
Aesthetic Surgery Journal Open Forum

Author: Andrea Felice Armenti, MD, PhD

Abstract: Recurrent herpes labialis (RHL) is a common condition characterized by episodic viral reactivation triggered by local or systemic factors. Hyaluronic acid (HA) lip augmentation is widely performed for aesthetic purposes, yet its potential association with changes in herpes labialis recurrence has not been systematically evaluated. The aim of this study was to investigate whether repeated lip augmentation with HA filler is associated with changes in the incidence of RHL episodes over time. A self-controlled longitudinal observational study was conducted in adult patients with a documented history of RHL undergoing lip augmentation with HA filler between 2016 and 2025. Each participant served as their own control, with recurrence rates compared across predefined baseline and posttreatment intervals. The primary outcome was the incidence of clinically typical herpes labialis episodes, expressed as episodes per person-year. Recurrent events were analyzed using generalized estimating equations with a negative binomial distribution. Ninety patients were included in the final analysis. Baseline incidence was 5.22 episodes per person-year. No significant change in recurrence rate was observed after the first filler session. A statistically significant reduction emerged after the second session (incidence rate ratio [IRR] 0.81; 95% CI, 0.72-0.91; P < .001) and became more pronounced after subsequent sessions. After 4 sessions, the IRR was 0.55 (95% CI, 0.45-0.66; P < .001). Recurrence rates stabilized after multiple treatments. In this longitudinal self-controlled cohort, repeated lip augmentation with HA filler was associated with a progressive reduction in RHL incidence after multiple sessions. The clinical relevance of this observed reduction was not predefined. Although causality cannot be established, the temporal pattern and statistical robustness of the findings warrant further investigation.

JOURNAL ARTICLE

Related Articles

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for inducing weight loss has increased in recent years, resulting in a parallel reduction in demand for bariatric surgery. Consequently, the need for patients to undergo aesthetic procedures, including aesthetic breast surgery, following successful GLP-1 RA–induced weight loss is expected to increase while the demand created by postsurgical weight loss is expected to decrease. The objective of this narrative review is to examine the literature on the use of GLP-1 RAs and other mechanisms used for medical weight loss to assist plastic surgeons in achieving optimal aesthetic outcomes with breast surgery after weight loss occurs.
Botulinum neurotoxin A (BoNT-A) is widely used clinically; yet, its temporary effects require repeated injections that increase cost and inconvenience. There is limited rigorous evidence to support claims that repeated BoNT-A use alters efficacy. Unlike peripheral nerve transection, which causes irreversible denervation after 12 to 24 months, the long-term physiological effects of BoNT-A chemodenervation remain unclear.